Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0JNTHN
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
1613F12-E-12
|
|||||
| Synonyms |
1613F12 E-12
Click to Show/Hide
|
|||||
| Organization |
Pierre Fabre SA.
|
|||||
| Drug Status |
Investigative
|
|||||
| Indication |
In total 1 Indication(s)
Renal cell carcinoma [ICD11:2C90]
Investigative
|
|||||
| Drug-to-Antibody Ratio |
3.5-5
|
|||||
| Antibody Name |
1613F12
|
Antibody Info | ||||
| Antigen Name |
Tyrosine-protein kinase receptor UFO (AXL)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
1613F12-E-12 linker
|
|||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.